UBS看好Tyra Biosciences股票,长期增长预期由TYRA-300管线驱动
UBS认为,在NASDAQ上市的Tyra Biosciences有潜力凭借其口服治疗方案引领市场。作为一种选择性FGFR3抑制剂,TYRA-300预计将比同时影响FGFR1、2和4的其他FGFR抑制剂提供更好的疗效和安全性。UBS分析师认为,TYRA-300在肿瘤学和生长障碍方面的长期机会比当前市场估值所反映的更为重要。
UBS以看跌评级开始覆盖SUSS MicroTec股票，目标价为40.30欧元
UBS分析师使用了三年期反向折现现金流 (DCF)模型来支撑目标价。基于该模型，当前股价暗示2024年至2027年的收入复合年增长率 (CAGR)为9%，这与UBS预估的-1%收入CAGR形成对比。
UBS upgrades Bank of America to Buy and boosts price target
UBS analysts upgrade Bank of America (BAC) to Buy from Neutral and lift their price target to $53 from $43. The analysts ...
Data Center Operator Digital Realty Is Now a Buy, Says UBS
Digital Realty shares rose 32% last year as demand for artificial intelligence capacity soared but data center space remained ...
UBS discusses the outlook for AI and the semiconductor industry
Nicolas Gaudois, head of Asia-Pacific technology research at UBS, discusses the main growth drivers for the names under its ...
UBS investigates undisclosed Nazi-linked accounts at Credit Suisse
Authorities entered impeached President Yoon Suk Yeol's compound, evading a crowd of protesters outside, but were confronted ...
China to erase excess solar-panel capacity by 2027, UBS forecasts
State-driven curbs on new facilities and production cuts by the biggest players will help rectify imbalance, analyst says.
腾讯网4 天
获法国巴黎银行唱多 瑞银(UBS.US)成欧股“最靓的仔”
智通财经APP获悉，瑞银(UBS.US)股价创下两个月来最大涨幅，此前法国巴黎银行证券部分析师Jeremy ...
腾讯网4 天
美股异动 | 获法国巴黎银行唱多 瑞银(UBS.US)盘前涨逾4%
智通财经APP获悉，周五， 瑞银 (UBS.US)美股盘前涨逾4%，报31.57美元。消息面上，此前法国巴黎银行证券部分析师Jeremy Sigee预期这家瑞士银行将增加 股票回购 ...
UBS Shares Rise as Exane Upgrades on Likely Buyback Increase
UBS Group AG shares rose the most in two months as analysts at BNP Paribas Exane recommended buying on expectations the Swiss ...
Boliden shares rise after UBS upgrades stock to 'neutral' rating
Investing.com -- Shares of Boliden (ST: BOL) rose over 3% on Tuesday following an upgrade to a 'neutral' rating by analysts ...